keyword
https://read.qxmd.com/read/38652826/induction-treatment-for-lupus-nephritis-at-a-high-complexity-hospital-in-chile
#1
JOURNAL ARTICLE
Paulina Ramirez, Andres Giglio, Jorge Verdugo, Francisco Gutierrez
INTRODUCTION: Systemic lupus erythematosus (SLE) causes kidney compromise in up to 40% of patients, contributing significantly to morbidity. Lupus nephritis (LN), an early onset manifestation in most patients, is histologically classified into six types, with types III, IV, and V requiring treatment with induction therapies, usually glucocorticoids with mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC). However, up to 60% of patients fail to achieve complete remission, and 27%-66% have subsequent flares...
April 23, 2024: Lupus
https://read.qxmd.com/read/38651106/case-report-chronic-inflammatory-demyelinating-polyneuropathy-superimposed-on-charcot-marie-tooth-type-1a-disease-after-sars-cov-2-vaccination-and-covid-19-infection
#2
Da Li, Hu Yu, Min Zhou, Weinv Fan, Qiongfeng Guan, Li Li
BACKGROUND: There is growing evidence that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or COVID-19 infection is associated with the development of immune mediated neuropathies like chronic inflammatory demyelinating polyneuropathy (CIDP), but the impact of SARS-CoV-2 vaccination and COVID-19 infection on genetic disorders such as Charcot-MarieTooth (CMT) remains unclear. CASE PRESENTATION: A 42-year-old male with occulted CMT neuropathy type lA (CMT1A) who developed limb numbness and weakness after the second SARS-CoV-2-vaccination was confirmed by identifying characteristic repeats in the p11...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38633948/navigating-treatment-dilemmas-recalcitrant-pemphigus-and-the-burden-of-multiple-comorbidities
#3
Priya Garg, Kshitiz Lakhey, Nishtha Mishra, Yash Buccha, Kirti S Deo
Pemphigus vulgaris is a chronic autoimmune disease of the skin caused by the production of autoantibodies targeting desmogleins 1 and 3 usually presenting in individuals with an average age of onset of approximately 40 years. A 35-year-old obese, diabetic woman presented with fluid-filled lesions over her body for three months along with erosions and painful ulcers in her mouth and genital area for two months. Based on clinical and histopathological studies, the patient was diagnosed as a case of pemphigus vulgaris...
March 2024: Curēus
https://read.qxmd.com/read/38589827/assessing-antiviral-treatment-efficacy-and-risk-factors-for-severe-covid-19-in-kidney-transplant-recipients-during-the-omicron-subvariant-dominant-period-a-retrospective-study
#4
JOURNAL ARTICLE
Takashi Sakaguchi, Akihiko Mitsuke, Yoichi Osako, Yasutoshi Yamada, Himawari Takeyama, Risako Ogawa, Katsuya Takahashi, Yukiko Hirohata, Sayuri Yamamoto, Junya Arima, Wataru Fukumoto, Satoshi Sugita, Satoru Inoguchi, Ryosuke Matsushita, Hirofumi Yoshino, Shuichi Tatarano, Hideki Enokida
BACKGROUND: Kidney transplant recipients (KTRs) are at risk of severe coronavirus disease 2019 (COVID-19), and even now that Omicron subvariants have become dominant, cases of severe disease are certain to occur. The aims of this retrospective study were to evaluate the efficacy of antiviral treatment for COVID-19 and to identify risk factors for severe disease in KTRs during Omicron subvariant-dominant periods. METHODS: A total of 65 KTRs diagnosed with COVID-19 who received antiviral treatment between July 2022 and September 2023 were analyzed...
April 8, 2024: BMC Nephrology
https://read.qxmd.com/read/38514155/treatment-of-myopathy-and-cutaneous-ulcers-in-anti-mda5-positive-dermatomyositis-with-triple-therapy
#5
JOURNAL ARTICLE
Gopisree Peringeth, Bhavna Abbi, Shereen Mahmood
Antimelanoma differentiation-associated protein 5 positive dermatomyositis (MDA5 DM) is a rare subtype of idiopathic inflammatory myopathy. There are limited data available regarding the cutaneous manifestations of MDA5 DM in the African American population. We presented the case of a male patient in his early 20s who presented with debilitating cutaneous ulceration and myopathy. Workup revealed interstitial lung disease (ILD) and positive MDA5 serology consistent with MDA5 DM. He made a remarkable recovery in terms of myopathy and cutaneous ulcerations with a multipronged regimen of prednisone, intravenous immunoglobulin and mycophenolate mofetil...
March 21, 2024: BMJ Case Reports
https://read.qxmd.com/read/38471694/enteric-coated-mycophenolate-sodium-therapy-versus-cyclophosphamide-for-induction-of-remission-in-microscopic-polyangiitis-emsar-mpa-trial-study-protocol-for-a-randomised-controlled-trial
#6
JOURNAL ARTICLE
Sijia Li, Shulei Yao, Xuan Tie, Xiaojing Shi, Rongrong Feng, Xiaole Su, Lihua Wang
INTRODUCTION: Several studies have demonstrated that mycophenolate mofetil (MMF) may be an excellent alternative to cyclophosphamide (CYC) or rituximab for the induction of remission in non-life-threatening anti-neutrophil cytoplasmic antibodies associated vasculitis because of its strong immunosuppressive potency and low toxicity profile. Enteric-coated mycophenolate sodium (EC-MPS) was introduced to reduce gastrointestinal adverse reactions of MMF. This study will evaluate the efficacy and safety of EC-MPS combined with glucocorticoid in patients with active and non-life-threatening microscopic polyangiitis (MPA)...
March 11, 2024: BMJ Open
https://read.qxmd.com/read/38466527/intravenous-cyclophosphamide-therapy-for-patients-with-severe-ocular-inflammatory-diseases-who-failed-other-immunomodulatory-therapies
#7
JOURNAL ARTICLE
Irmak Karaca, Elaine M Tran, SungWho Park, Albert Bromeo, Hassan Khojasteh, Anh Ngọc Tram Tran, Negin Yavari, Amir Akhavanrezayat, Cigdem Yasar, Gunay Uludag Kirimli, Ngoc Tuong Trong Than, Muhammad Hassan, Christopher Or, Hashem Ghoraba, Diana V Do, Quan Dong Nguyen
BACKGROUND: Ocular inflammatory diseases, including scleritis and uveitis, have been widely treated with immunomodulatory therapies (IMTs) as a steroid-sparing approach. Such strategy includes conventional therapies (antimetabolites, alkylating agents, and calcineurin inhibitors) as well as biologic agents like adalimumab, infliximab, rituximab, and tocilizumab. Cyclophosphamide (CP) is an alkylating agent and mainly inhibits the functioning of both T and B cells. Though known to have potential adverse events, including bone marrow suppression, hemorrhagic cystitis, and sterility, CP has been shown to be efficacious, especially in recalcitrant cases and when used intravenous (IV) for a limited period...
March 11, 2024: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/38465811/-modern-aspects-of-diagnosis-and-treatment-of-chronic-inflammatory-demyelinating-polyneuropathy-in-children
#8
JOURNAL ARTICLE
A A Kozyreva, R Ts Bembeeva, E S Druzhinina, N N Zavadenko, L M Kolpakchi, S V Pilia
OBJECTIVE: Analysis of demographic, clinical, laboratory, electrophysiological and neuroimaging data and pathogenetic therapy of pediatric patients with chronic inflammatory demyelinating polyneuropathy (CIDP). MATERIAL AND METHODS: Patients ( n =30) were observed in a separate structural unit of the Russian Children's Clinical Hospital of the Russian National Research Medical University named after. N.I. Pirogova Ministry of Health of the Russian Federation in the period from 2006 to 2023...
2024: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38459811/epstein-barr-virus-associated-colitis-in-kidney-transplant-patients-a-case-series
#9
JOURNAL ARTICLE
Ana Catarina Brás, Sara Querido, André Mascarenhas, Raquel Mendes, Rita Verissimo, Cristina Chagas, André Weigert
BACKGROUND: Gastrointestinal complications are common in kidney transplant (KT) patients and can be a consequence of the chronic use of immunosuppression. The differential diagnosis of colitis in KT patients includes intolerance to immunosuppressive agents, namely mycophenolate mofetil, de novo inflammatory bowel disease (IBD) and opportunistic infections. Epstein-Barr virus (EBV) infection may cause post-transplant colitis or trigger de novo IBD, although is seldom thought as the causative pathogen...
March 9, 2024: Infectious Diseases
https://read.qxmd.com/read/38449620/coexistence-of-anti-nmdar-and-anti-iglon5-antibodies-in-an-autoimmune-encephalitis-patient-the-first-case-report
#10
Yu Tian, Lu Han, Cameron Lenahan, Tao Wang, Tian Tian, Rui Liu, Lijuan Liu, Jian Huang, Lu Wang, Xiao Hu
BACKGROUND: The coexistence of autoimmune encephalitis (AE) with multiple neural auto-antibodies is of great clinical significance because overlying antibodies may cause superposition or variation of clinical syndrome, which increases the difficulty of diagnosis and treatment of the disease. To the best of our knowledge, the coexistence of anti-N-methyl d-aspartate Receptor (NMDAR) and anti-IgLON5 antibodies in AE has not been published previously. CASE PRESENTATION: A 38-year-old female patient presented to our hospital due to headache and abnormal psychiatric behavior...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38437813/severe-recurrence-and-retinal-inflammatory-infiltration-after-cessation-of-immunosuppression-for-multifocal-choroiditis-and-panuveitis
#11
JOURNAL ARTICLE
Jeannette Ossewaarde-van Norel, Richard F Spaide
PURPOSE: To describe a severe recurrence of intraocular inflammation following the cessation of immunosuppression, previously administered for multifocal choroiditis and panuveitis (MCP). METHODS: Retrospective chart review. RESULTS: A 27-year-old woman with MCP initially was treated with intravenous and oral corticosteroids and photodynamic therapy because of an active macular neovascularization in both eyes. Mycophenolate was soon started and the recurrences during tapering of the oral corticosteroids in the first months were treated with periocular corticosteroids and anti-vascular endothelial growth factor injections as they became available...
March 4, 2024: Retinal Cases & Brief Reports
https://read.qxmd.com/read/38435981/chronic-inflammatory-demyelinating-polyradiculoneuropathy-current-therapeutic-approaches-and-future-outlooks
#12
REVIEW
Yusuf A Rajabally
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a treatable autoimmune disorder, for which different treatment options are available. Current first-line evidence-based therapies for CIDP include intravenous and subcutaneous immunoglobulins, corticosteroids and plasma exchanges. Despite lack of evidence, cyclophosphamide, rituximab and mycophenolate mofetil are commonly used in circumstances of refractoriness and, more debatably, of perceived overdependence on first-line therapies. Rituximab is currently the object of a randomized controlled trial for CIDP...
2024: ImmunoTargets and Therapy
https://read.qxmd.com/read/38423680/treatment-of-pyoderma-gangrenosum
#13
REVIEW
Marcus G Tan, Stanislav N Tolkachjov
Pyoderma gangrenosum is a rare neutrophilic dermatosis that results in painful cutaneous ulcers and is frequently associated with underlying hematologic disorders, inflammatory bowel disease, or other autoimmune disorders. Pathogenesis involves an imbalance between proinflammatory and anti-inflammatory mediators, leading to tissue damage from neutrophils. First-line treatment options with the greatest evidence include systemic corticosteroids, cyclosporine, and tumor necrosis factor alpha inhibitors. Other steroid-sparing therapies such as dapsone, mycophenolate mofetil, intravenous immunoglobulin, and targeted biologic or small molecule inhibitors also have evidence supporting their use...
April 2024: Dermatologic Clinics
https://read.qxmd.com/read/38388292/high-dose-intravenous-immunoglobulin-to-treat-anti-thymocyte-globulin-induction-related-bk-virus-and-cytomegalovirus-infection-in-patients-with-abo-incompatible-kidney-transplantation
#14
JOURNAL ARTICLE
Jin Ho Lee, Heeryong Lee, Kipyo Kim, Seoung Woo Lee, Joon Ho Song, Seun Deuk Hwang
BACKGROUND: ABO-incompatible (ABOi) transplantation is a novel method transplantation method that carries a heightened risk of infection caused by the use of high immunosuppressant doses. This elevated risk is particularly concerning for viral infections, such as cytomegalovirus (CMV) and the BK virus (BKV) increases. Herein, we present a case where high-dose intravenous immunoglobulin (IVIG) was effective in treating viral infections after transplantation. METHODS: A 41-year-old man underwent an ABOi transplantation...
February 21, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38379641/case-report-thrombotic-thrombocytopenic-purpura-in-a-pregnant-woman-with-lupus-membranous-nephropathy-a-diagnostic-challenge
#15
Marina Leiva, Gustavo Navarro, J Daniel Carpio, Leopoldo Ardiles
A 27-year-old female at 20th week of pregnancy was admitted with edema, foamy urine, but normal blood pressure. Her blood count was normal, she had proteinuria of 3 g/day, creatinine 0.4 mg/dl, albumin 2.4 g/dl, and cholesterol 355 mg/dl. Antinuclear antibodies 1/160, but Anti-DNA, anticardiolipin antibodies and lupus anticoagulant were negative, with normal serum C3 and C4. A renal biopsy showed secondary membranous glomerulopathy, most likely lupus class V pure. Steroids, azathioprine, and aspirin were initiated, up to 28 weeks of pregnancy, when she developed severe hypertension, photopsia, headache, anasarca, extensive bruising of the extremities, severe anemia, thrombocytopenia, and creatinine rose to 2...
2024: Front Nephrol
https://read.qxmd.com/read/38375823/diagnosis-and-management-of-immune-mediated-liver-injury-from-checkpoint-inhibitors
#16
JOURNAL ARTICLE
Alisa Likhitsup, Robert J Fontana
PURPOSE OF REVIEW: The aim is to summarize the latest data on the incidence, clinical manifestations, and management of immune- mediated liver injury from checkpoint inhibitors (ILICI). RECENT FINDINGS: ILICI develops in 10-15% of oncology patients receiving immunotherapy with most having asymptomatic serum aminotransferase and/or alkaline phosphatase elevations. Most grade 1-2 ILICI patients improve with drug discontinuation and/or short-term oral corticosteroids...
February 16, 2024: Current Opinion in Gastroenterology
https://read.qxmd.com/read/38350929/treatment-of-scleredema-adultorum-of-buschke-with-intravenous-immunoglobulin-and-mycophenolate-mofetil-in-a-14-year-old-girl-a-case-report
#17
JOURNAL ARTICLE
Mehran Pournazari, Dena Mohamadzadeh, Shirin Assar, Mazaher Ramezani
BACKGROUND: Scleredema adultorum of Buschke is a rare disease characterized by firm and non-pitting edema of the skin. The condition is rare with unknown etiology. Diagnosis is made on the basis of clinical findings and skin biopsy. CASE PRESENTATION: Here, we describe a 14-year-old Iranian girl presenting with non-pitting edema and woody thickening of the skin that progressed within a month. She was evaluated for possible underlying malignancy or connective tissue disorders, which were excluded by multiple laboratory workups...
February 14, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38344403/resistant-anemia-in-a-kidney-transplant-recipient-pure-red-cell-aplasia-due-to-parvovirus-b19-infection
#18
Hassan Choudry, Fateh Chattah, Hilal Shalla, Farooq Ghulam, Saddam Hussain Abbasi, Jorge Jesus-Silva
Anemia in kidney transplant recipients can stem from a diverse array of etiologies, including dietary deficiencies, inflammatory processes, allograft dysfunction, as well as viral and bacterial infections. We present a case of refractory anemia in a 49-year-old male patient occurring within the initial month following a kidney transplant, which persisted despite numerous transfusions, posing a formidable challenge. The patient was maintained on the standard immunosuppressant regimen-Tacrolimus, Mycophenolate, and Prednisolone...
2024: Qatar Medical Journal
https://read.qxmd.com/read/38335710/predictors-of-relapsing-disease-course-following-index-event-in-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-mogad
#19
JOURNAL ARTICLE
Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, Gauruv Bose, Itay Lotan, Gabriela Romanow, Monique R Anderson, Marcelo Matiello, Tanuja Chitnis, Michael Levy
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an autoimmune disease that can present as a monophasic or relapsing disease course. Here, we investigate the predictors of developing relapsing disease with a focus on the index event. METHODS: MOGAD patients followed at Massachusetts General Hospital and Brigham and Women's Hospital were included. Data on demographic, clinical, and laboratory features were collected. Time-to-event survival analysis was performed using a Cox proportional hazards model...
January 30, 2024: Journal of the Neurological Sciences
https://read.qxmd.com/read/38321574/generalized-myasthenia-gravis-with-acetylcholine-receptor-antibodies-a-guidance-for-treatment
#20
JOURNAL ARTICLE
Nils Erik Gilhus, Henning Andersen, Linda Kahr Andersen, Marion Boldingh, Sini Laakso, Margret Oddny Leopoldsdottir, Sidsel Madsen, Fredrik Piehl, Trine Haug Popperud, Anna Rostedt Punga, Liselotte Schirakow, John Vissing
BACKGROUND: Generalized myasthenia gravis (MG) with antibodies against the acetylcholine receptor is a chronic disease causing muscle weakness. Access to novel treatments warrants authoritative treatment recommendations. The Nordic countries have similar, comprehensive health systems, mandatory health registers, and extensive MG research. METHODS: MG experts and patient representatives from the five Nordic countries formed a working group to prepare treatment guidance for MG based on a systematic literature search and consensus meetings...
February 6, 2024: European Journal of Neurology
keyword
keyword
111288
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.